查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1907941

避孕藥市場按藥丸類別、荷爾蒙成分、活性成分含量、黃體素生成、用戶年齡層、處方狀態、品牌類型、應用需求、包裝類型、分銷管道和地區分類

Contraceptive Pills Market, By Pill Category, By Hormonal Composition,By Dosage Strength, By Progestin Generation, By User Age Group, By Prescription Status, By Brand Type,By Application Need,By Packaging Format, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，避孕藥具市場價值為 81.2 億美元，到 2032 年將達到 131.2 億美元，2025 年至 2032 年的複合年成長率為 7.1%。

分析範圍 分析詳情
基準年 2024 市場規模（2025 年） 81.2億美元
效能數據 2020-2024 預測期 2025-2032
預測期（2025-2032 年）複合年成長率 7.10% 預計金額（2032 年） 131.2億美元

全球避孕藥市場是生殖健康產業的重要組成部分，其中包括口服避孕藥。口服避孕藥旨在透過調節荷爾蒙機制來預防意外懷孕。這些藥物主要含有合成雌激素和黃體素，它們透過抑制排卵、改變子宮頸黏液的性狀以及改變子宮內膜，從而形成多重受孕屏障。

自1960年代首款口服避孕藥問世以來，市場發生了顯著變化，從最初的基礎荷爾蒙製劑發展到如今更先進、劑量更低的組合藥物，在保持療效的同時，最大限度地減少了副作用。現代避孕藥分為複方製劑（含有雌激素和黃體素）和單方製劑（僅含有黃體素），每種製劑都為不同的患者群提供獨特的益處。

該行業透過多種配方滿足消費者的各種需求，包括單相、雙相、三相、長週期避孕藥和事後緊急避孕藥。該市場在一個複雜的生態系統中運作，涉及製藥企業、醫療保健機構、監管機構和終端用戶，其通路涵蓋醫院、診所、藥房以及不斷擴展的線上平台。避孕藥市場持續推動醫療領域的創新，滿足消費者對更便利、更少副作用和更強的非避孕治療益處的不斷變化的需求。

市場動態

全球避孕市場正經歷強勁成長，這主要得益於幾個相互關聯的因素：政府主導的促進避孕措施普及和教育計畫提高了人們對計劃生育和生殖健康的認知，尤其是在發展中地區，這是市場擴張的主要驅動力。

全球女性勞動參與率的不斷提高，催生了對可靠避孕方法的需求，使女性能夠根據自身職業目標規劃生育。同時，對女性賦權和生殖權利的日益重視，進一步加速了避孕方法的普及。許多國家醫療基礎設施的改善和避孕藥具保險覆蓋範圍的擴大，推動了市場滲透。此外，持續的產品創新，例如低劑量荷爾蒙和新的給藥方式，透過減少副作用和改善用戶體驗，也為市場提供了支持。

然而，市場有許多限制，例如保守社會中對避孕藥具使用的文化和宗教反對，這限制了某些地區的市場滲透率；此外，長期使用激素避孕藥具的安全問題，包括血栓症、心血管併發症和情緒障礙風險增加，也讓潛在用戶和醫療保健提供者猶豫不決。

嚴格的避孕產品核准流程增加了研發成本和上市時間，而子宮內避孕器、植入和屏障避孕法等其他避孕方法的存在加劇了市場競爭。新興市場中存在著巨大的機遇，這些市場年輕人口不斷成長，個人化荷爾蒙解決方案得益於新技術，避孕藥在痤瘡、子宮內膜異位症和卵巢症候群（PCOS）等疾病的治療用途也日益廣泛。這些因素擴大了潛在市場規模，並開啟了新的收入來源。

本報告的主要特點

  • 本報告對全球避孕藥市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和複合年成長率，以 2024 年為基準年。
  • 它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
  • 根據公司概況、產品系列、主要亮點、財務表現和策略等參數，對全球避孕藥具市場的主要企業進行了分析。
  • 本報告提供的見解將使負責人和公司經營團隊能夠就未來的產品發布、產品更新、市場擴張和行銷策略做出明智的決策。
  • 《全球避孕藥具市場》報告面向該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過各種用於分析全球避孕藥具市場的策略矩陣，更輕鬆地做出決策。

目錄

第1章 分析目標與先決條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 重大進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特五力分析
  • 企業合併情景
  • 產業趨勢

4. 全球避孕藥市場（按片劑類別分類）（2020-2032 年）

  • 複方口服避孕藥（COCs）
  • 僅含黃體素的片劑（POP/迷你丸）
  • 事後緊急避孕藥（ECP）

5. 全球避孕藥市場（依荷爾蒙配方分類）（2020-2032 年）

  • 單相片劑
  • 雙相片劑
  • 三相片

6. 全球避孕藥市場依活性成分含量分類（2020-2032 年）

  • 低劑量藥片
  • 標準劑量藥片
  • 高劑量藥片

7. 全球避孕藥市場（以黃體素代數分類）（2020-2032 年）

  • 第一代黃體素片
  • 第二代孕激素片
  • 第三代黃體素片
  • 第四代孕激素片

8. 全球避孕藥具市場依使用者年齡層分類（2020-2032 年）

  • 15至19歲
  • 20-29歲
  • 30-39歲
  • 40歲或以上

9. 全球避孕藥市場（依處方狀態分類）（2020-2032 年）

  • 處方箋藥
  • 非處方藥

第10章 全球避孕藥具市場（依品牌類型分類）（2020-2032 年）

  • 非專利的
  • 品牌藥

第11章 全球避孕市場依應用需求分類（2020-2032 年）

  • 避孕
  • 荷爾蒙調節
  • 痤瘡治療
  • 月經週期管理

第12章 全球避孕藥具市場按包裝類型分類（2020-2032 年）

  • 21天裝
  • 24天裝
  • 28 天裝
  • 91天裝

13. 全球避孕藥具市場按通路分類（2020-2032 年）

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第14章 全球避孕藥具市場（按地區分類）（2020-2032 年）

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東地區
  • 非洲
    • 南非
    • 北非
    • 中非

第15章 競爭格局

  • Pfizer Inc
  • Bayer AG
  • Organon &Co
  • Teva Pharmaceutical Industries Ltd
  • Mylan NV（Viatris Inc）
  • Johnson &Johnson
  • Gedeon Richter Plc
  • Lupin Limited
  • Cipla Limited
  • HLL Lifecare Limited
  • Piramal Enterprises Limited
  • Sun Pharmaceutical Industries Ltd
  • Allergan plc（AbbVie Inc）
  • Cadila Healthcare Ltd（Zydus Lifesciences）
  • Torrent Pharmaceuticals Ltd

第16章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map (COM)

第17章 參考文獻與分析方法

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI9024

Contraceptive Pills Market is estimated to be valued at USD 8.12 Bn in 2025 and is expected to reach USD 13.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.12 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.10% 2032 Value Projection: USD 13.12 Bn

The global contraceptive pills market represents a critical segment of the reproductive health industry, encompassing oral contraceptive medications designed to prevent unwanted pregnancies through hormonal regulation mechanisms. These pharmaceutical products, primarily containing synthetic versions of estrogen and progestin hormones, work by suppressing ovulation, altering cervical mucus consistency, and modifying the uterine lining to create multiple barriers against conception.

The market has evolved significantly since the introduction of the first oral contraceptive in the 1960s, transforming from basic hormonal formulations to sophisticated, low-dose combinations that minimize side effects while maintaining efficacy. Modern contraceptive pills are categorized into combination pills containing both estrogen and progestin, and progestin-only pills, each offering distinct advantages for different patient demographics.

The industry serves diverse consumer needs through various formulations including monophasic, biphasic, and triphasic pills, extended-cycle options, and emergency contraceptives. This market operates within a complex ecosystem involving pharmaceutical manufacturers, healthcare providers, regulatory bodies, and end-users, with distribution channels spanning hospitals, clinics, pharmacies, and increasingly, online platforms. The contraceptive pills market continues to drive innovation in reproductive healthcare, addressing evolving consumer preferences for convenience, reduced side effects, and enhanced therapeutic benefits beyond contraception.

Market Dynamics

The global contraceptive pills market experiences robust growth driven by multiple interconnected factors, with increasing awareness about family planning and reproductive health serving as the primary catalyst for market expansion, particularly in developing regions where government initiatives promote contraceptive accessibility and education programs enhance understanding of birth control options.

Rising female workforce participation globally creates demand for reliable contraceptive methods that enable women to plan pregnancies according to career goals, while growing emphasis on women's empowerment and reproductive rights further accelerates adoption rates. Healthcare infrastructure improvements and expanding insurance coverage for contraceptives in many countries facilitate market penetration, supported by continuous product innovations that reduce side effects and improve user experience through lower hormone doses and novel delivery mechanisms.

However, the market faces significant restraints including cultural and religious opposition to contraceptive use in conservative societies, which limits market penetration in certain geographic regions, while safety concerns regarding long-term hormonal contraceptive use, including increased risks of blood clots, cardiovascular complications, and mood disorders, create hesitancy among potential users and healthcare providers.

Stringent regulatory requirements for contraceptive approval processes increase development costs and time-to-market, while the availability of alternative contraceptive methods such as intrauterine devices, implants, and barrier methods intensifies competitive pressure. Significant opportunities lie in underserved emerging markets with rising youth populations, personalized hormone solutions enabled by new technologies, and broader therapeutic uses of contraceptive pills for acne, endometriosis, and PCOS, which expand the total addressable market and unlock new revenue streams.

Key Features of the Study

  • This report provides in-depth analysis of the global contraceptive pills market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global contraceptive pills market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc, Bayer AG, Organon & Co, Teva Pharmaceutical Industries Ltd, Mylan NV (Viatris Inc), Johnson & Johnson, Gedeon Richter Plc, Lupin Limited, Cipla Limited, HLL Lifecare Limited, Piramal Enterprises Limited, Sun Pharmaceutical Industries Ltd, Allergan plc (AbbVie Inc), Cadila Healthcare Ltd (Zydus Lifesciences), and Torrent Pharmaceuticals Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global contraceptive pills market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive pills market

Market Segmentation

  • Pill Category Insights (Revenue, USD Bn, 2020 - 2032)
    • Combined oral contraceptive pills (COCs)
    • Progestin-only pills (POPs/mini-pills)
    • Emergency contraceptive pills (ECPs)
  • Hormonal Composition Insights (Revenue, USD Bn, 2020 - 2032)
    • Monophasic Pills
    • Biphasic Pills
    • Triphasic Pills
  • Dosage Strength Insights (Revenue, USD Bn, 2020 - 2032)
    • Low-Dose Pills
    • Standard-Dose Pills
    • High-Dose Pills
  • Progestin Generation Insights (Revenue, USD Bn, 2020 - 2032)
    • First-Generation Progestin Pills
    • Second-Generation Progestin Pills
    • Third-Generation Progestin Pills
    • Fourth-Generation Progestin Pills
  • User Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • 15-19 years
    • 20-29 years
    • 30-39 years
    • 40+ years
  • Prescription Status Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription-Based Pills
    • Over-the-Counter Pills
  • Brand Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Generic
    • Branded
  • Application Need Insights (Revenue, USD Bn, 2020 - 2032)
    • Birth Control
    • Hormonal Regulation
    • Acne Management
    • Menstrual Cycle Management
  • Packaging Format Insights (Revenue, USD Bn, 2020 - 2032)
    • 21-Day Pack
    • 24-Day Pack
    • 28-Day Pack
    • 91-Day Pack
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc
    • Bayer AG
    • Organon & Co
    • Teva Pharmaceutical Industries Ltd
    • Mylan NV (Viatris Inc)
    • Johnson & Johnson
    • Gedeon Richter Plc
    • Lupin Limited
    • Cipla Limited
    • HLL Lifecare Limited
    • Piramal Enterprises Limited
    • Sun Pharmaceutical Industries Ltd
    • Allergan plc (AbbVie Inc)
    • Cadila Healthcare Ltd (Zydus Lifesciences)
    • Torrent Pharmaceuticals Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contraceptive Pills Market, By Pill Category
    • Global Contraceptive Pills Market, By Hormonal Composition
    • Global Contraceptive Pills Market, By Dosage Strength
    • Global Contraceptive Pills Market, By Progestin Generation
    • Global Contraceptive Pills Market, By User Age Group
    • Global Contraceptive Pills Market, By Prescription Status
    • Global Contraceptive Pills Market, By Brand Type
    • Global Contraceptive Pills Market, By Application Need
    • Global Contraceptive Pills Market, By Packaging Format
    • Global Contraceptive Pills Market, By Distribution Channel
    • Global Contraceptive Pills Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contraceptive Pills Market, By Pill Category, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Combined oral contraceptive pills (COCs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Progestin-only pills (POPs/mini-pills)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Emergency contraceptive pills (ECPs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contraceptive Pills Market, By Hormonal Composition, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Monophasic Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biphasic Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Triphasic Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contraceptive Pills Market, By Dosage Strength, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Low-Dose Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Standard-Dose Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • High-Dose Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contraceptive Pills Market, By Progestin Generation, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • First-Generation Progestin Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Second-Generation Progestin Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Third-Generation Progestin Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fourth-Generation Progestin Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Contraceptive Pills Market, By User Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 15-19 years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 20-29 years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 30-39 years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 40+ years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Contraceptive Pills Market, By Prescription Status, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription-Based Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Contraceptive Pills Market, By Brand Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Contraceptive Pills Market, By Application Need, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Birth Control
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hormonal Regulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Acne Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Menstrual Cycle Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Contraceptive Pills Market, By Packaging Format, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 21-Day Pack
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 24-Day Pack
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 28-Day Pack
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 91-Day Pack
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Contraceptive Pills Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

14. Global Contraceptive Pills Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Pill Category, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Hormonal Composition, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Progestin Generation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Brand Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application Need, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Packaging Format, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

15. Competitive Landscape

  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organon & Co
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan NV (Viatris Inc)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gedeon Richter Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cipla Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HLL Lifecare Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Piramal Enterprises Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Allergan plc (AbbVie Inc)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cadila Healthcare Ltd (Zydus Lifesciences)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Torrent Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

16. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

17. References and Research Methodology

  • References
  • Research Methodology
  • About us